Research
August 25, 2021
NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study
Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).
August 19, 2021
UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana
UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.
July 21, 2021
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
June 1, 2021
Jenkins to Help Lead Clinical Trials Expansion at UAMS Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Amy Jo Jenkins, M.S., CCRP, recently joined the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead the Early Phase Clinical Trials at the University of Arkansas for Medical Sciences (UAMS).
May 11, 2021
UAMS Cancer Researcher Hong-yu Li, Ph.D., Awarded $1.27 Million Grant
LITTLE ROCK — Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), recently received a five-year, $1,265,834 grant from the National Institutes of Health and the National Cancer Institute to work toward developing treatment options for acute myeloid leukemia patients. Li, a professor…
April 20, 2021
UAMS Cancer Researcher Receives $1.1 Million as Part of NIH Grant at University of Arkansas, Fayetteville
A National Institutes of Health (NIH) grant will allow UAMS researcher Isabelle Racine Miousse, Ph.D., to ramp up her study of a nutrient that may have a role in the effectiveness of immunotherapy for cancer patients. Miousse will receive $220,000 per year for up to five years as one of four project leaders at the…
April 12, 2021
Cancer DNA Blood Tests Validated By International Research Team
LITTLE ROCK — An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing – a fast, cheap and less invasive method to diagnose and monitor cancer.
April 6, 2021
UAMS Researchers Named Arkansas Research Alliance Scholar, Fellow
LITTLE ROCK — The Arkansas Research Alliance (ARA) announced today that two researchers at the University of Arkansas for Medical Sciences will be joining their ranks.
March 24, 2021
Four UAMS Cancer Institute Scientists Receive Research Grants
Four researchers at the UAMS Winthrop P. Rockefeller Cancer Institute received a funding boost thanks to newly awarded $50,000 grants, which were announced in a virtual ceremony March 11. Presented annually since 2009, the Seeds of Science pilot grant awards assist cancer researchers in collecting data and developing projects that have the potential to result…
Next page